Agoracom: Small Cap Investment - Pluristem Life Systems, Inc. - U.S. FDA Clears Pluristem’s IND Application for Phase II COVID-19 Study

patented technology to grow and expand adult Stem Cells

Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place

Reply New Message

Back To Forum List View

emit

Rank: Vice President [?]

Points: 41186 [?]

Votes: 199 Score: 3.0 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

U.S. FDA Clears Pluristem’s IND Application for Phase II COVID-19 Study

posted on May 10, 2020 06:37PM

https://finance.yahoo.com/news/u-fda-clears-pluristem-ind-100010757.html

Reply New Message

Back To Forum List View

Please to post a reply